Public case informationLast updated
GRAIL Securities Class Action
GRAIL · GRAIL common stock and the NHS-Galleri cancer screening trial · Ongoing Litigation
About this case
A securities class action alleges that GRAIL made false or misleading statements about the results of its NHS-Galleri trial while concealing adverse facts, allegedly violating federal securities laws. The lawsuit is in litigation, and the stated lead-plaintiff deadline was August 4, 2026.
Case overview
- Defendant company
- GRAIL
- Product or service
- GRAIL common stock and the NHS-Galleri cancer screening trial
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Lead Plaintiff Application
Participation information
Lead Plaintiff Application
Shareholders who purchased GRAIL shares during the stated class period and allegedly suffered losses were encouraged to contact the law firm regarding a possible lead-plaintiff appointment.
Contact DJS Law Group regarding a possible lead-plaint appointment.
- Type
- Lead Plaintiff
- Status
- Deadline passed
- Reported proof requirement
- Unclear
Sources
- GRAIL Securities Class Action
Barchart.com ·
- GRAIL Securities Class Action
Barchart.com ·